Ann Woolley

Infectious disease physician, with a focus on transplant, hepatitis, and cardiac infections @BrighamWomens @harvardmed

[Ann Woolley @AnnWoolleyMD]

@KottonNelson Thanks so much Camille! Appreciate it. Will be great for our work at MGB too.

[Ann Woolley @AnnWoolleyMD]

@GaboMotoa @harvardmed @mgh_id @BrighamWomens He is the best of the best!

[Infectious Diseases Community of Practice - AST @AST_IDCOP]

📢📢Trainee poster! ID fellow @MGHBWHIDFellows @bwh_id Dr. Alisse Hannaford @AlisseHannaford presenting on RSV vaccination responses in SOT patients at #ATC2024Philly @AST_IDCOP @AST_info @AnnWoolleyMD @Dr_AmyKacin

Congrats on being a poster winner!!

[Ann Woolley @AnnWoolleyMD]

@TorontoIDDoc @BradSpellberg @DrToddLee @dralicehan The POET II trial that is currently enrolling will help to answer this question

[Cesar G. Berto, MD @CesarGBerto]

Excited to present a case for Clinical Grand Rounds at @ESCMID

Interesting cases & teaching points from all around the world 🌎

[Ann Woolley @AnnWoolleyMD]

Excellent and thought provoking talk on the challenges associated with bacterial donor derived infections by @mularoni So nice to chair this session with you! @ECCMID

[Alessandra Mularoni @mularoni]

The challenge of Donor Derived infections @AnnWoolleyMD you did a great job!

[Carol Garcia-Vidal @c_garciavidal]

IMPORTANT CONCLUSIONS!
@mhdezmeneses @hospitalclinic @idibaps
#ESCMIDGlobal2024

[Michael Ison, MD MS @MichaelGIsonMD]

Master class in MDROs - risks, prevention and management in SOT BY Maddalena Giannella @ECCMID @ESCMID

[Anna Apostolopoulou, MD @AnnaApostolopo3]

If at #ECCMID24, feel free to stop by my poster (Sector B/Row 23) today at noon to discuss the effect of immune checkpoint inhibitors on neutrophil function against C.albicans

[Erika Kampouri @ErikaKampouri]

Important work by txid ⭐️ @JessicaLittleMD @ESCMID infection density increases after bsAb therapy, more opportunistic & life-threatening infections! Come chat p3777!

[Eileen Maziarz @EileenMaziarz]

@RicardoLaHozMD conceptual framework for consideration of #LTx donors with resp viral infection. #HowLongToWait - a critically important ? for 🫁transplant programs. Superb talk! @ISHLT2024 @UTSWInfDis

[Ricardo M. La Hoz @RicardoLaHozMD]

Antimicrobial management of LVAD infections by @StephaniePouch! @ISHLT #ISHLT2024

[camwolfe @camwolfe]

NOTHING better than seeing a prior fellow becoming an absolute international rockstar!!

Well done @emilymeich - beautifully presented study on why presatovir didn’t help RSV in lung transplants.
@ISHLT @DukeAdultID

[Ricardo M. La Hoz @RicardoLaHozMD]

Combatting infection in LVAD patients - an outstanding talk by @AnnWoolleyMD @ISHLT #ISHLT2024

[Clinical Infectious Diseases @CIDJournal]

Recommendations detailing a standardized approach for using PET/CT and SPECT/CT imaging to improve the evaluation and subsequent outcomes of patients with cardiovascular infection.

✅ Just Accepted
🆓 Freely Available
https://t.co/SG1YbpvDsv

[Abhay Dhand @DhandAbhay]

@AnnWoolleyMD giving Transplant Grand Rounds @WestchesterMed/@nymedcollege.
Looking forward to learning her expertise in expanding the donor pool and managing donor derived infections in transplant recipients.

[Ann Woolley @AnnWoolleyMD]

@DhandAbhay @WestchesterMed @nymedcollege Thanks for having me!

[American Society of Transplantation (AST) @AST_info]

Thank you @RepJerryNadler, for your unwavering support of living donors!

[Ann Woolley @AnnWoolleyMD]

@AMostaghimi @JosephMerolaMD @bwhdermatology Congratulations! Excellent news.

[Paul Sax @PaulSaxMD]

Remarkable RCT from Norway demonstrating that starting HCV treatment in the hospital with newly diagnosed HCV among PWIDs is superior to deferring therapy to outpatient care in achieving HCV cure.

Results argue for broader use. @HMidgard @selihep https://t.co/BspdLy5hGR